The association between BsmI polymorphism and risk factors for atherosclerosis in patients with epilepsy taking valproate
To evaluate the association between the BsmI polymorphism and vascular risk factors or metabolic syndrome in patients with epilepsy treated with valproate.
Gespeichert in:
| Autor*in: |
Phabphal, Kanitpong [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2013 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
6 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Differential methylation of a CpG site in the CD95-ligand promoter predicts the response to therapy with APG101 in glioblastoma - Gieffers, C. ELSEVIER, 2016, Oxford [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:22 ; year:2013 ; number:9 ; pages:692-697 ; extent:6 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.seizure.2013.05.003 |
|---|
| Katalog-ID: |
ELV039006743 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV039006743 | ||
| 003 | DE-627 | ||
| 005 | 20230624053749.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.seizure.2013.05.003 |2 doi | |
| 028 | 5 | 2 | |a GBVA2013017000027.pica |
| 035 | |a (DE-627)ELV039006743 | ||
| 035 | |a (ELSEVIER)S1059-1311(13)00148-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.52 |2 bkl | ||
| 100 | 1 | |a Phabphal, Kanitpong |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The association between BsmI polymorphism and risk factors for atherosclerosis in patients with epilepsy taking valproate |
| 264 | 1 | |c 2013 | |
| 300 | |a 6 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a To evaluate the association between the BsmI polymorphism and vascular risk factors or metabolic syndrome in patients with epilepsy treated with valproate. | ||
| 650 | 7 | |a Epilepsy |2 Elsevier | |
| 650 | 7 | |a Atherosclerosis |2 Elsevier | |
| 650 | 7 | |a Vitamin D polymorphism |2 Elsevier | |
| 650 | 7 | |a Valproate |2 Elsevier | |
| 700 | 1 | |a Geater, Alan |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Gieffers, C. ELSEVIER |t Differential methylation of a CpG site in the CD95-ligand promoter predicts the response to therapy with APG101 in glioblastoma |d 2016 |g Oxford [u.a.] |w (DE-627)ELV019641362 |
| 773 | 1 | 8 | |g volume:22 |g year:2013 |g number:9 |g pages:692-697 |g extent:6 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.seizure.2013.05.003 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a GBV_ILN_65 | ||
| 912 | |a GBV_ILN_70 | ||
| 912 | |a GBV_ILN_252 | ||
| 936 | b | k | |a 44.52 |j Therapie |x Medizin |q VZ |
| 951 | |a AR | ||
| 952 | |d 22 |j 2013 |e 9 |h 692-697 |g 6 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
k p kp |
|---|---|
| matchkey_str |
phabphalkanitponggeateralan:2013----:hascainewebmplmrhsadikatrfrteoceoiiptet |
| hierarchy_sort_str |
2013 |
| bklnumber |
44.52 |
| publishDate |
2013 |
| allfields |
10.1016/j.seizure.2013.05.003 doi GBVA2013017000027.pica (DE-627)ELV039006743 (ELSEVIER)S1059-1311(13)00148-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.52 bkl Phabphal, Kanitpong verfasserin aut The association between BsmI polymorphism and risk factors for atherosclerosis in patients with epilepsy taking valproate 2013 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To evaluate the association between the BsmI polymorphism and vascular risk factors or metabolic syndrome in patients with epilepsy treated with valproate. Epilepsy Elsevier Atherosclerosis Elsevier Vitamin D polymorphism Elsevier Valproate Elsevier Geater, Alan oth Enthalten in Elsevier Gieffers, C. ELSEVIER Differential methylation of a CpG site in the CD95-ligand promoter predicts the response to therapy with APG101 in glioblastoma 2016 Oxford [u.a.] (DE-627)ELV019641362 volume:22 year:2013 number:9 pages:692-697 extent:6 https://doi.org/10.1016/j.seizure.2013.05.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_65 GBV_ILN_70 GBV_ILN_252 44.52 Therapie Medizin VZ AR 22 2013 9 692-697 6 045F 610 |
| spelling |
10.1016/j.seizure.2013.05.003 doi GBVA2013017000027.pica (DE-627)ELV039006743 (ELSEVIER)S1059-1311(13)00148-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.52 bkl Phabphal, Kanitpong verfasserin aut The association between BsmI polymorphism and risk factors for atherosclerosis in patients with epilepsy taking valproate 2013 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To evaluate the association between the BsmI polymorphism and vascular risk factors or metabolic syndrome in patients with epilepsy treated with valproate. Epilepsy Elsevier Atherosclerosis Elsevier Vitamin D polymorphism Elsevier Valproate Elsevier Geater, Alan oth Enthalten in Elsevier Gieffers, C. ELSEVIER Differential methylation of a CpG site in the CD95-ligand promoter predicts the response to therapy with APG101 in glioblastoma 2016 Oxford [u.a.] (DE-627)ELV019641362 volume:22 year:2013 number:9 pages:692-697 extent:6 https://doi.org/10.1016/j.seizure.2013.05.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_65 GBV_ILN_70 GBV_ILN_252 44.52 Therapie Medizin VZ AR 22 2013 9 692-697 6 045F 610 |
| allfields_unstemmed |
10.1016/j.seizure.2013.05.003 doi GBVA2013017000027.pica (DE-627)ELV039006743 (ELSEVIER)S1059-1311(13)00148-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.52 bkl Phabphal, Kanitpong verfasserin aut The association between BsmI polymorphism and risk factors for atherosclerosis in patients with epilepsy taking valproate 2013 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To evaluate the association between the BsmI polymorphism and vascular risk factors or metabolic syndrome in patients with epilepsy treated with valproate. Epilepsy Elsevier Atherosclerosis Elsevier Vitamin D polymorphism Elsevier Valproate Elsevier Geater, Alan oth Enthalten in Elsevier Gieffers, C. ELSEVIER Differential methylation of a CpG site in the CD95-ligand promoter predicts the response to therapy with APG101 in glioblastoma 2016 Oxford [u.a.] (DE-627)ELV019641362 volume:22 year:2013 number:9 pages:692-697 extent:6 https://doi.org/10.1016/j.seizure.2013.05.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_65 GBV_ILN_70 GBV_ILN_252 44.52 Therapie Medizin VZ AR 22 2013 9 692-697 6 045F 610 |
| allfieldsGer |
10.1016/j.seizure.2013.05.003 doi GBVA2013017000027.pica (DE-627)ELV039006743 (ELSEVIER)S1059-1311(13)00148-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.52 bkl Phabphal, Kanitpong verfasserin aut The association between BsmI polymorphism and risk factors for atherosclerosis in patients with epilepsy taking valproate 2013 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To evaluate the association between the BsmI polymorphism and vascular risk factors or metabolic syndrome in patients with epilepsy treated with valproate. Epilepsy Elsevier Atherosclerosis Elsevier Vitamin D polymorphism Elsevier Valproate Elsevier Geater, Alan oth Enthalten in Elsevier Gieffers, C. ELSEVIER Differential methylation of a CpG site in the CD95-ligand promoter predicts the response to therapy with APG101 in glioblastoma 2016 Oxford [u.a.] (DE-627)ELV019641362 volume:22 year:2013 number:9 pages:692-697 extent:6 https://doi.org/10.1016/j.seizure.2013.05.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_65 GBV_ILN_70 GBV_ILN_252 44.52 Therapie Medizin VZ AR 22 2013 9 692-697 6 045F 610 |
| allfieldsSound |
10.1016/j.seizure.2013.05.003 doi GBVA2013017000027.pica (DE-627)ELV039006743 (ELSEVIER)S1059-1311(13)00148-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.52 bkl Phabphal, Kanitpong verfasserin aut The association between BsmI polymorphism and risk factors for atherosclerosis in patients with epilepsy taking valproate 2013 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To evaluate the association between the BsmI polymorphism and vascular risk factors or metabolic syndrome in patients with epilepsy treated with valproate. Epilepsy Elsevier Atherosclerosis Elsevier Vitamin D polymorphism Elsevier Valproate Elsevier Geater, Alan oth Enthalten in Elsevier Gieffers, C. ELSEVIER Differential methylation of a CpG site in the CD95-ligand promoter predicts the response to therapy with APG101 in glioblastoma 2016 Oxford [u.a.] (DE-627)ELV019641362 volume:22 year:2013 number:9 pages:692-697 extent:6 https://doi.org/10.1016/j.seizure.2013.05.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_65 GBV_ILN_70 GBV_ILN_252 44.52 Therapie Medizin VZ AR 22 2013 9 692-697 6 045F 610 |
| language |
English |
| source |
Enthalten in Differential methylation of a CpG site in the CD95-ligand promoter predicts the response to therapy with APG101 in glioblastoma Oxford [u.a.] volume:22 year:2013 number:9 pages:692-697 extent:6 |
| sourceStr |
Enthalten in Differential methylation of a CpG site in the CD95-ligand promoter predicts the response to therapy with APG101 in glioblastoma Oxford [u.a.] volume:22 year:2013 number:9 pages:692-697 extent:6 |
| format_phy_str_mv |
Article |
| bklname |
Therapie |
| institution |
findex.gbv.de |
| topic_facet |
Epilepsy Atherosclerosis Vitamin D polymorphism Valproate |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Differential methylation of a CpG site in the CD95-ligand promoter predicts the response to therapy with APG101 in glioblastoma |
| authorswithroles_txt_mv |
Phabphal, Kanitpong @@aut@@ Geater, Alan @@oth@@ |
| publishDateDaySort_date |
2013-01-01T00:00:00Z |
| hierarchy_top_id |
ELV019641362 |
| dewey-sort |
3610 |
| id |
ELV039006743 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV039006743</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624053749.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.seizure.2013.05.003</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013017000027.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV039006743</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1059-1311(13)00148-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.52</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Phabphal, Kanitpong</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The association between BsmI polymorphism and risk factors for atherosclerosis in patients with epilepsy taking valproate</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">To evaluate the association between the BsmI polymorphism and vascular risk factors or metabolic syndrome in patients with epilepsy treated with valproate.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Epilepsy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Atherosclerosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vitamin D polymorphism</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Valproate</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Geater, Alan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Gieffers, C. ELSEVIER</subfield><subfield code="t">Differential methylation of a CpG site in the CD95-ligand promoter predicts the response to therapy with APG101 in glioblastoma</subfield><subfield code="d">2016</subfield><subfield code="g">Oxford [u.a.]</subfield><subfield code="w">(DE-627)ELV019641362</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:22</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:9</subfield><subfield code="g">pages:692-697</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.seizure.2013.05.003</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_252</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.52</subfield><subfield code="j">Therapie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">22</subfield><subfield code="j">2013</subfield><subfield code="e">9</subfield><subfield code="h">692-697</subfield><subfield code="g">6</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Phabphal, Kanitpong |
| spellingShingle |
Phabphal, Kanitpong ddc 610 bkl 44.52 Elsevier Epilepsy Elsevier Atherosclerosis Elsevier Vitamin D polymorphism Elsevier Valproate The association between BsmI polymorphism and risk factors for atherosclerosis in patients with epilepsy taking valproate |
| authorStr |
Phabphal, Kanitpong |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV019641362 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 610 VZ 44.52 bkl The association between BsmI polymorphism and risk factors for atherosclerosis in patients with epilepsy taking valproate Epilepsy Elsevier Atherosclerosis Elsevier Vitamin D polymorphism Elsevier Valproate Elsevier |
| topic |
ddc 610 bkl 44.52 Elsevier Epilepsy Elsevier Atherosclerosis Elsevier Vitamin D polymorphism Elsevier Valproate |
| topic_unstemmed |
ddc 610 bkl 44.52 Elsevier Epilepsy Elsevier Atherosclerosis Elsevier Vitamin D polymorphism Elsevier Valproate |
| topic_browse |
ddc 610 bkl 44.52 Elsevier Epilepsy Elsevier Atherosclerosis Elsevier Vitamin D polymorphism Elsevier Valproate |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
a g ag |
| hierarchy_parent_title |
Differential methylation of a CpG site in the CD95-ligand promoter predicts the response to therapy with APG101 in glioblastoma |
| hierarchy_parent_id |
ELV019641362 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Differential methylation of a CpG site in the CD95-ligand promoter predicts the response to therapy with APG101 in glioblastoma |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV019641362 |
| title |
The association between BsmI polymorphism and risk factors for atherosclerosis in patients with epilepsy taking valproate |
| ctrlnum |
(DE-627)ELV039006743 (ELSEVIER)S1059-1311(13)00148-9 |
| title_full |
The association between BsmI polymorphism and risk factors for atherosclerosis in patients with epilepsy taking valproate |
| author_sort |
Phabphal, Kanitpong |
| journal |
Differential methylation of a CpG site in the CD95-ligand promoter predicts the response to therapy with APG101 in glioblastoma |
| journalStr |
Differential methylation of a CpG site in the CD95-ligand promoter predicts the response to therapy with APG101 in glioblastoma |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2013 |
| contenttype_str_mv |
zzz |
| container_start_page |
692 |
| author_browse |
Phabphal, Kanitpong |
| container_volume |
22 |
| physical |
6 |
| class |
610 610 DE-600 610 VZ 44.52 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Phabphal, Kanitpong |
| doi_str_mv |
10.1016/j.seizure.2013.05.003 |
| dewey-full |
610 |
| title_sort |
association between bsmi polymorphism and risk factors for atherosclerosis in patients with epilepsy taking valproate |
| title_auth |
The association between BsmI polymorphism and risk factors for atherosclerosis in patients with epilepsy taking valproate |
| abstract |
To evaluate the association between the BsmI polymorphism and vascular risk factors or metabolic syndrome in patients with epilepsy treated with valproate. |
| abstractGer |
To evaluate the association between the BsmI polymorphism and vascular risk factors or metabolic syndrome in patients with epilepsy treated with valproate. |
| abstract_unstemmed |
To evaluate the association between the BsmI polymorphism and vascular risk factors or metabolic syndrome in patients with epilepsy treated with valproate. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_65 GBV_ILN_70 GBV_ILN_252 |
| container_issue |
9 |
| title_short |
The association between BsmI polymorphism and risk factors for atherosclerosis in patients with epilepsy taking valproate |
| url |
https://doi.org/10.1016/j.seizure.2013.05.003 |
| remote_bool |
true |
| author2 |
Geater, Alan |
| author2Str |
Geater, Alan |
| ppnlink |
ELV019641362 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth |
| doi_str |
10.1016/j.seizure.2013.05.003 |
| up_date |
2024-07-06T19:34:50.425Z |
| _version_ |
1803859515593981952 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV039006743</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624053749.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.seizure.2013.05.003</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013017000027.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV039006743</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1059-1311(13)00148-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.52</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Phabphal, Kanitpong</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The association between BsmI polymorphism and risk factors for atherosclerosis in patients with epilepsy taking valproate</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">To evaluate the association between the BsmI polymorphism and vascular risk factors or metabolic syndrome in patients with epilepsy treated with valproate.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Epilepsy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Atherosclerosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vitamin D polymorphism</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Valproate</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Geater, Alan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Gieffers, C. ELSEVIER</subfield><subfield code="t">Differential methylation of a CpG site in the CD95-ligand promoter predicts the response to therapy with APG101 in glioblastoma</subfield><subfield code="d">2016</subfield><subfield code="g">Oxford [u.a.]</subfield><subfield code="w">(DE-627)ELV019641362</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:22</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:9</subfield><subfield code="g">pages:692-697</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.seizure.2013.05.003</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_252</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.52</subfield><subfield code="j">Therapie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">22</subfield><subfield code="j">2013</subfield><subfield code="e">9</subfield><subfield code="h">692-697</subfield><subfield code="g">6</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.4019012 |